Company record · updated October 7, 2026
Medical Microinstruments Inc: 5 valuation observations from SEC filings
Every row below names the filing it came from. Coverage for this company runs October 31, 2024 to September 30, 2025.
5observations
5source filings
5verified rows
2025-09-30most recent as-of date
Source rails for this company: N-PORT fund mark (5).
Reported by 4 filers: Fidelity Advisor Health Care Fund, Fidelity Series Growth Company Fund, Select Health Care Portfolio, VIP Stock Selector Portfolio.
| As of | Measure | Value | Reported by | Tier | What the filing says | Accession |
|---|---|---|---|---|---|---|
| 2025-09-30 | price per share | 12.13 USD | VIP Stock Selector Portfolio | VERIFIED | valUSD 13840.33 / balance 1141.0 [pp] | 000003540225002317 |
| 2025-08-31 | price per share | 12.16 USD | Fidelity Series Growth Company Fund | VERIFIED | valUSD 37805.44 / balance 3109.0 [pp] | 000003540225001412 |
| 2025-04-30 | price per share | 12.36 USD | Fidelity Advisor Health Care Fund | VERIFIED | valUSD 123377.52 / balance 9982.0 [pp] | 000175272425159806 |
| 2024-11-30 | price per share | 12.27 USD | Select Health Care Portfolio | VERIFIED | valUSD 194050.05 / balance 15815.0 [pp] | 000175272425015317 |
| 2024-10-31 | price per share | 12.21 USD | Fidelity Advisor Health Care Fund | VERIFIED | valUSD 121880.22 / balance 9982.0 [pp] | 000175272424297782 |
Reading these figures
A fund mark is the filer's own fair-value estimate at a quarter end, not a transaction price, and two filers can reach different values for the same date. A charter round price is the issue price of that series at issuance. Neither is a current market price.